Evolution Wealth Advisors, LLC Baxter International Inc Transaction History

Evolution Wealth Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$74.57 - $87.19 $5,518 - $6,452	-74 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$73.77 - $83.61 $10,327 - $11,705	-140 Reduced 65.42%	74 $6,000
Q2 2021 Jul 22, 2021	SELL	$80.5 - $88.01 $5,554 - $6,072	-69 Reduced 24.38%	214 $17,000
Q1 2021 Apr 20, 2021	SELL	$76.38 - $86.03 $1,145 - $1,290	-15 Reduced 5.03%	283 $24,000
Q4 2020 Feb 02, 2021	SELL	$75.39 - $82.36 $4,372 - $4,776	-58 Reduced 16.29%	298 $24,000
Q2 2020 Jul 27, 2020	BUY	$78.66 - $94.14 $6,528 - $7,813	83 Added 30.4%	356 $31,000
Q1 2020 Apr 22, 2020	SELL	$71.57 - $93.3 $59,045 - $76,972	-825 Reduced 75.14%	273 $22,000
Q4 2019 Feb 03, 2020	BUY	$76.7 - $88.45 $81,992 - $94,553	1,069 Added 3686.21%	1,098 $92,000
Q3 2019 Nov 12, 2019	SELL	$81.4 - $89.78 $29,466 - $32,500	-362 Reduced 92.58%	29 $3,000
Q2 2019 Jul 12, 2019	BUY	$73.44 - $82.41 $28,715 - $32,222	391 New	391 $32,000

981

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.8B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.